Pharmacy Learning Network - Home

Peter Pitts, former associate commissioner at the US FDA and president of the Center for Medicine in the Public Interest, discusses why the FDA pulled a large quantity of a blood pressure drugs off the market and why it is important to understand.   | Read More
The FDA has approved trastuzumab-dttb (Ontruzant; Merck), as a biosimilar to trastuzumab (Herceptin; Genentech) for the treatment of certain patients with HER2-overexpressing breast cancer or metastatic gastric or gastroesophageal junction adenocarcinoma. | Read More
Pharmacogenomics testing might help to identify less effective medications for patients with major depressive disorder, according to results from a recent trial. | Read More
The FDA is recalling a prescription antibiotic used to treat a range of bacterial infections. | Read More